ResApp Receives $1.785 Million R&D Tax Incentive Cash Rebate

View printer-friendly version Brisbane, Australia, 12 June 2019 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today announced that it has received...

Breathe Easy Paediatric Study Published in Peer-Reviewed Journal

View printer-friendly version Brisbane, Australia, 6 June 2019 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce the publication...

ResApp Appoints Renowned Healthcare Leaders to Industry Advisory Board

View printer-friendly version Brisbane, Australia, 5 June 2019 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today announced that it has appointed...